Program, May 29
6th ESES Workshop Hyperparathyroidism due multiple gland disease: An evidence-based perspective Scientific Program Friday, May 29, 2015 |
08:15 – 08:30 |
|
08:30 – 10:30 |
OP9. Is recurrent/persistent disease following focused parathyroidectomy caused by multiglandular disease? OP10. Sestamibi scanning fails to localise parathyroid adenomas with different set points OP11. Subtotal parathyroidectomy for secondary renal hyperparathyroidism: twenty-year surgical outcome study OP12. Time to recurrence in less than subtotal parathyroidectomy for MEN 1 primary hyperparathyroidism favors individualized surgical concept OP13. Lithium-associated hyperparathyroidism: prevalence and surgical results OP14. Is there an Increased Risk for Malignant Parathyroid Tumors in Latvia when comparing Latvian and German Patients with Primary Hyperparathyroidism? OP15. Usefulness of parathyroid hormone washout after fine-needle aspiration biopsy in patients with equivocal localization studies OP16. Importance of the screening and the surgical treatment in the evolution of the hyperparathyroidism in MEN1 |
10:30 – 11:00 |
|
11:00 – 12:30 |
|
12:30 - 13:00 |
|
13:00 – 14:00 |
PP 1. Cancer incidence in thyroid nodules ≥4cm with benign cytology PP 2. Benefits and risks of preoperative vitamin D supplementation in primary hyperparathyroidism – results from a randomized controlled trial PP 3. Adrenalectomy in lesions highly suggestive for metastasis: Is imaging more than enough? PP 4.The potential utility of BRAF V600E status follow-up in FNA of thyroid nodules PP 5. Bilateral axillo-breast approach (BABA) robotic thyroid surgery does not affect breast imaging PP 6. Routine calcitonin screening in nodular thyroid disease management: Is it appropriate in detecting early stage medullary cancer? PP 7. Clinical experiences of parathyroid carcinoma in single institution PP 8. Incidence of thyroid cancer in post-transplant patients in Korea; An Institutional Review of Thyroid Cancer Incidence in Post-transplant Patients in Korea PP 9. Giant parathyroid adenomas PP 10. Management of Parathyroid Carcinoma: experience of three centers in Western Turkey PP 11. MEN syndromes patients treatment in one Endocrine Surgery Center PP 12. Rate of multiglandular disease (MD) among institutional series of surgically treated primary hyperparathyroidism (PHPT) PP 13. One year experience of single institute in surgical treatment of secondary hyperparathyroidism PP 14. Failure of fragmented parathyroid gland autotransplantation to prevent permanent hypoparathyroidism after total thyroidectomy PP 15. Parathyroid score can predict duration of calcium requirement after total thyroidectomy PP 16. Planned bilateral neck exploration in suspected multigland parathyroid disease PP 17. Comparative study of postoperative pain for open versus BABA robotic thyroidectomy using a self-reporting application for iPad PP 18. Comparative Outcomes of Lateral Transperitoneal Adrenalectomy Versus Posterior Retroperitoneoscopic Adrenalectomy PP 19. Preoperative localization studies in patients with secondary hyperparathyroidism. Is it better now? PP 20. Prevalence and patterns of recurrent papillary carcinoma after optimized surgery PP 21. PTH analysis in the biopsy needle washout- a rational method in the initial diagnosis of parathyroid disorders - Our six years of experience PP 22. The results of surgical treatment of primary and secondary hyperparathyroidism PP 23. Surgical approach to secondary hyperparathyroidism. Ectopic parathyroid glands in patients, who underwent dialysis PP 24. Surgical management of secondary hyperparathyroidism: How to effectively reduce recurrence at the time of primary surgery PP 25. Surgical treatment of secondary hyperparathyroidism: single institution statistics, trends, complications and results PP 26. Synchronous parathyroid tumors and thyroid carcinomas cases treatment PP 27. Thyroid cancer with macroscopic tumor thrombus at the veins: a complex management PP 28. Prediction of multiglandular disease by intraoperative quick PTH assay PP 29. Variations of intra- and postoperative parathormone levels of patients with parathyroid adenoma PP 30. Which biochemical and clinical parameters correlate with parathyroid adenomas’ weight? A regional comparative study PP 31. Hyperparathyroidism: the experience of a center PP 32. Hyperparathyroidism in MEN2a syndrome. surgical and genetics implications PP 33. Parathyroid carcinoma as the cause of primary hyperparathyroidism PP 34. Primary hyperpathyroidism due to cystic huge parathyroid carcinoma PP 35. Surgical Site Infection and Group A Streptoccocus Infection after Thyroidectomy and Parathyroidectomy VP 1 Single port thoracoscopic treatment of cervical ductus thoracicus injury after neck dissection accompanying thyroidectomy |
14:00 - 14:40 |
Genetic basis of parathyroid multiple gland disease |
14:40 - 15:00 |
|
15:00 – 16:30 |
Panelists: F. Palazzo, B. Carnaille, M.R. Vriens |
16:30 - 17:00 |
|
17:00 – 17:30 |
|
17:30 – 18:00 |
|
18:00 – 19:15 |
CR1. Unrecognized parathyroid carcinoma 15 years after initial operation for primary hyperparathyroidism and 18 years after operation for brown tumors in pelvis and jaws: a case report CR2. Hypercalcaemic crisis due to primary hyperparathyroidism — a systematic literature review and case report CR3. Multicentric parathyroid carcinoma in chronic renal insufficiency patient CR4. Parathyroid cancer - six cases report CR5. Post-parathyroidectomy hypercalcaemia caused by unexpected genetic mutation |
20:00 |
|
Sponsors:
Gold Sponsor
Bronze Sponsor